US
If visiting the DiaSorin Site from a region that doesn't coincide with your location, some products may not be available. This is due to regulatory requirements and restrictions.
21/12/18 - 11:30
DiaSorin launches 3 new primer pairs for use in molecular testing (438.25 KB)
Products
Molecular
19/11/18 - 15:00
DiaSorin launches Simplexa Group B Strep Direct molecular assay in the United States (435.43 KB)
Products
Molecular
17/10/18 - 11:51
DiaSorin launches Simplexa Group B Strep Direct molecular assay in the european market (147.78 KB)
Products
Molecular
12/10/18 - 11:47
DiaSorin launches Simplexa VZV Direct molecular assay in the european market (444.81 KB)
Products
Molecular
17/09/18 - 11:28
DiaSorin launches the new LIASON quantiFERON-TB Gold Plus assay as an aid for latent tuberculosis detection in partnership with Qiagen (753.85 KB)
Products
Immunodiagnostic
27/07/18 - 12:00
DiaSorin launches Hepatitis Delta (HDV) test on LIAISON XL platform (735.03 KB)
Products
Immunodiagnostic
12/06/18 - 14:15
DiaSorin introduces primer pair reagents for use in molecular testing: Anaplasma phagocytophilum, Ehrlichia e Babesia (445.17 KB)
Products
Molecular
05/04/18 - 12:00
DiaSorin receives FDA clearance for the LIAISON BRAHMS PCT II GEN assay to detect severe bacterial infections (e.g. Sepsis) (737.88 KB)
Products
Immunodiagnostic
28/03/18 - 18:45
DiaSorin earns FDA clearence extending sample claims for Simplexa HSV 1 & 2 direct molecular test (442.69 KB)
Products
Molecular